ARCHIVES

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 43 | November 10, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: Healy to Name Jay Moskowitz Deputy Direct, Promote Mahoney To Deputy Budge Director

March 6, 1992

NCAB, President’s Cancer Panel honor the late Paul Calabresi.

June 11, 2004

Cancer Death Rate Declines, Clark Tells Science Writers

April 8, 1977

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

October 20, 2000

DRCCA Board Votes To Pull NCI Out Of Joint Program With OSHA For Workplace Education And Prevention

January 29, 1982

Senate Approves Supplemental Funds For NIH and FDA.

May 23, 2008